This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 171.43% and 4.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Idexx Laboratories (IDXX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Idexx (IDXX) delivered earnings and revenue surprises of 9.88% and 1.70%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 88.89% and 8.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Teleflex (TFX) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Teleflex (TFX) delivered earnings and revenue surprises of 4.04% and 3.51%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of -3.57% and 1.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 107.14% and 4.82%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Edwards Lifesciences (EW) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 4.92% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Tactile Systems Technology (TCMD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tactile Systems Technology (TCMD) stock based on the movements in the options market lately.
Despite Fast-paced Momentum, Tactile Systems Technology (TCMD) Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tactile Systems Technology (TCMD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Terex and Armstrong World Industries have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Terex and Armstrong World Industries are part of the Zacks Bull and Bear of the Day article.
3 Medical Instruments Stocks on Recovery Path After Dismal 2022
by Indrajit Bandyopadhyay
Here we discuss three medical instruments stocks - TCMD, VCYT and NVCN - that have started to recover in the past few months after declining for the major part of 2022.
The Zacks Analyst Blog Highlights ShockWave Medical, iRadimed and Tactile Systems Technology
by Zacks Equity Research
ShockWave Medical, iRadimed and Tactile Systems Technology are part of the Zacks top Analyst Blog.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Tactile Systems Technology (TCMD)
by Zacks Equity Research
Tactile Systems Technology (TCMD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Wall Street Analysts Think Tactile Systems Technology (TCMD) Could Surge 168%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 168.2% upside potential for Tactile Systems Technology (TCMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
3 Medical Instruments Stocks With Potential to Outperform
by Indrajit Bandyopadhyay
Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.
Wall Street Analysts Believe Tactile Systems Technology (TCMD) Could Rally 188%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Tactile Systems Technology (TCMD) points to an 187.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Tactile Systems Technology (TCMD) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 200% and 8.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Moves 6.6% Higher: Will This Strength Last?
by Zacks Equity Research
Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Tactile Systems Technology (TCMD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 12.50% and 4.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -35.48% and 6.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Teleflex (TFX) delivered earnings and revenue surprises of 5.49% and 1.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -566.67% and 6.03%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Tactile Systems Technology (TCMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tactile Systems Technology (TCMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for December 31st
by Zacks Equity Research
GFF, NHI, ROCC, USFD, and TCMD have been added to the Zacks Rank #5 (Strong Sell) List on December 31, 2021.
4 Toxic Stocks to Eliminate From Your Portfolio Now
by Rimmi Singhi
Detecting toxic stocks and dumping them at the right time is crucial to avoid big losses. ILMN, TCMD, CTOS and GCI are a few toxic stocks that don't deserve a place in your portfolio.